ASND
Ascendis Pharma A/S
$229.01
+0.66% (+$1.51)
Volume
887,720
52W High
$248.60
52W Low
$124.06
Market Cap
$13.70B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.39
Whisper EPS
$0.33
15.0% below consensus
Last Quarter
-$0.55
Current Streak
3 Misss
Avg Surprise (4Q)
-229.04%
Next Earnings Report
Reports in 47 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 12, 2026
1-Day:
-0.82%
5-Day:
+2.43%
Q4 2025
Feb 11, 2026
1-Day:
-1.53%
Q3 2025
Nov 6, 2025
1-Day:
-0.77%
5-Day:
+0.94%
Q2 2025
Aug 7, 2025
1-Day:
+0.60%
5-Day:
+2.96%
Revenue & Financial Performance
Revenue Whisper
$490.4M
TWN Proprietary Estimate
Last Quarter Revenue
$245.2M
+41.0% YoY
Gross Margin
88.9%
Net Margin: -13.6%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $245.2M | +41.0% | 88.9% | 4.0% | -$33.2M |
| Q3'25 | $213.6M | +269.4% | 89.5% | 5.2% | -$61.0M |
| Q2'25 | $158.0M | +339.0% | 80.1% | -33.5% | -$38.9M |
| Q1'25 | $101.0M | +5.3% | 82.7% | -103.2% | -$94.6M |
| Q4'24 | $173.9M | +26.3% | 91.9% | 0.2% | -$38.5M |
| Q3'24 | $57.8M | +20.4% | 80.6% | -167.3% | -$99.2M |
| Q2'24 | $36.0M | -24.0% | 68.2% | -370.2% | -$109.4M |
| Q1'24 | $95.9M | +185.5% | 92.1% | -51.3% | -$131.0M |
Company Information
Symbol
ASND
Company
Ascendis Pharma A/S
Market Cap
$13.70B
Next Earnings
Apr 30, 2026